13

LIVEDaily Stock Market Report (Thur 19th Nov 2026) - Agenda

There’s been an announcement by Anthropic confirming key details of its IPO.

  • New ticker: ANT, to begin trading today.

  • 980 million shares have been sold at $83 per share ($81 billion raised)

According to Bloomberg, the valuation is around $1.5 trillion.

There was also a $26 billion private placement, so the total raised is over $107 billion. It’s the biggest IPO of all time.

Selling shareholders have only sold 23.6 million shares as part of the IPO.

The initial target price range was $70-$78, so the company and its bankers have indeed beaten that.

Following all of the recent drama at Nvidia, it’s going to be another exciting day for AI-related news as the market digests this IPO - and probably a better one. Anthropic’s StockReport (mostly empty) is available here.

Overnight market movements:

  • The FTSE is up 0.2% at 10,570

  • S&P 500 is up 1.1% at 7,400

  • Brent crude (January) is up 0.3% at $92.25/bbl

  • Gold is up 0.2% at $3,734/oz

  • Bitcoin is up 2.4% at $63,700


Roland Head & Mark Simpson are here today!
The table is being edited.


Companies Reporting

Name (Mkt Cap)

RNS

AI Summary

Notes

GSK (LON:GSK) (£75.2bn | SR72)

Velzatinib obtains ODD in Japan for GIST treatment

Velzatinib, a novel, highly selective KIT inhibitor, has received Orphan Drug Designation from Japan’s Ministry of Health Labour and Welfare for the treatment of gastrointestinal stromal tumour (GIST). GSK is accelerating the development of velzatinib, with phase III trials under way in first- and second-line advanced / metastatic GIST.

Halma (LON:HLMA) (£12.9bn | SR52)

Half Year Results

The interim dividend rises 7% to 10.30p per share, up from 9.63p, payable on 29 January 2027. That is the only result in the announcement itself, which gives no profit, revenue or outlook figures for the six months to 30 September 2026. Shareholders on the register on 18 December 2026 qualify, and the dividend reinvestment election closes on 8 January 2027.

Sage group (LON:SGE) (£10.2bn | SR50)

Sage Group PLC (The) - Results for the year ended 30 September 2026

Underlying revenue rose 11% to £2,783m in the year to September 2026, and underlying operating profit rose 13% to £681m. The final dividend lifts the full-year payout 8% to 23.60p, but net debt rose to £1,582m after £604m of buybacks. A restructuring charge of about £100m is expected in FY27, and management expects “organic total revenue growth in FY27 to be in the region of 10%”.

Babcock International (LON:BAB) (£4.7bn | SR24)

Babcock HY27 half year results

Profit rose and full-year expectations are unchanged. Underlying operating profit climbed 13% to £227.3m, helped by nuclear and aviation, and the interim dividend rose 12% to 2.8p. Contract backlog fell to £8.9bn from £9.9bn. A large nuclear contract is expected to be signed in November.

Investec (LON:INVP) (£5.3bn | SR64)

FY27 Interim Results 30SEP26

Adjusted earnings per share rose 7.4% to 43.5p in the first half, and the interim dividend rose to 18.5p from 17.5p. Return on equity slipped to 13.5% from 13.6% as costs grew 9.7%, ahead of revenue growth of 6.7%. Management says the investment programme is “on track” to lift returns from FY2028.

JD Sports Fashion (LON:JD.) (£4.4bn | SR93)

JD Sports Fashion - Q3 2026/27 TRADING STATEMENT

Profit guidance has been narrowed to £700m–£750m from £700m–£800m, and the company said trading was in line with expectations. Third-quarter organic sales fell 1.1% (second quarter: down 1.3%), with footwear still soft. Free cash flow guidance of £460m–£520m is unchanged, and the £200m buyback is complete.

Greatland Resources (LON:GGP) (£3.1bn | SR82)

Greatland Resources - 2026 AGM Chairman’s Address & Presentation

Telfer produced about 329,000oz of gold last financial year and Havieron has moved into construction. All-in sustaining costs were below $2,200/oz, on about $270m of capital spending, and cash stood at $1.29bn on 30 June. The chairman's priorities are keeping Telfer productive, building Havieron "well" and continuing exploration.

Johnson Matthey (LON:JMAT) (£2.9bn | SR43)

Johnson Matthey half year results

Underlying operating profit rose 32% in the half and full-year guidance is raised to high single-digit growth, after a £1bn payout to shareholders. Clean Air margin reached 14.2%. First-half free cash outflow was £98m on PGM inventory, expected to unwind in the second half.

MITIE (LON:MTO) (£2.7bn | SR60)

H1 FY27 Results

Operating profit before one-off items rose 14% to £124m in the half to September, and all strategic plan targets are expected to be met. Statutory operating profit fell to £44m because of £79m of one-off costs, including deal and integration costs. The OCS cash takeover, at 218.5p a share, is expected to complete in Q1 2027.

TAKEOVER

HUTCHMED (China) (LON:HCM) (£1.8bn | SR33)

Hutchmed Highlights Hmpl: A830 Pre-Clinical Data

Preclinical data for HMPL‑A830, a first-in-class Antibody-Targeted Therapy Conjugate drug candidate. HMPL‑A830 exhibited high binding affinity and rapid internalization into EGFR-positive cells. In mouse models, HMPL-A830 showed dose-dependent and robust antitumor efficacy.

Great Portland Estates (LON:GPE) (£1.4bn | SR41)

Another strong half-year performance

Rental income lifted earnings in the half: EPRA earnings per share rose 43.6% to 5.6p, and EPRA NTA per share rose 3.2% to 541p. Leasing secured £19.0m of annual rent, 4.1% above March rental values. Net debt rose to £900.0m, but pro forma loan-to-value after the £368.7m sale is 21.9%. Rental growth guidance of 4–7% is reiterated.

Grainger (LON:GRI) (£1.3bn | SR48)

Preliminary Full Year Financial Results

EPRA earnings rose 12% to £60.2m in the year to September 2026, hitting the company's earnings target, but valuation falls produced a £41.8m IFRS pre-tax loss. EPRA net tangible assets per share fell 6% to 281p. The final dividend is up, lifting the total 3% to 8.56p, and the board is “targeting” £72m earnings by FY29.

Breedon (LON:BREE) (£1.1bn | SR86)

Trading Update to 31 October 2026

Earnings expectations are down after energy-led cost inflation proved hard to recover through pricing. The group now expects full-year underlying EBITDA at the lower end of the £272m–£286m market range. Revenue for the first ten months rose 7%, with growth in each division. Covenant leverage is expected to be about 2.0x for the year.

XPS Pensions (LON:XPS) (£733m | SR73)

Half-year Report

Revenue rose 12% to £144.3m in the half year, and adjusted pre-tax profit rose 12% to £31.3m. Reported pre-tax profit fell 12% to £12.1m after £19.3m of acquisition-related and other non-trading costs. Net debt was £73.0m after the APR acquisition. The board is “confident of achieving full year results in line with its recently upgraded expectations”.

PayPoint (LON:PAY) (£429m | SR98)

Half year results for the six months ended 30 September 2026

Profit fell in the half, with pre-tax profit down 13.2% on weaker parcels volumes, but the board still expects the year to be "broadly in line with market expectations". Underlying pre-tax profit was £22.3m, and net revenue fell 3.3% to £81.9m. Performance is weighted to the second half. Net debt rose to £138.3m from £132.5m as buybacks continued, and the interim dividend is up 2.0% to 20.2p.

SThree (LON:STEM) (£378m | SR98)

Circle8 Group Inc. - CIRC: Rule 2.8 Statement re SThree plc (STEM.L)

Circle8 now confirms that it does not intend to make an offer for SThree.

TAKEOVER

McBride (LON:MCB) (£302m | SR64)

AGM Trading Update

Profit expectations are cut as margin recovery slips two quarters, to Q4 FY27. The board now expects FY27 adjusted EBITA 20–25% below analysts' expectations, which stand at £62.9m. In the first quarter, like-for-like volumes rose about 2% and revenue about 4%, but cost pressures and operational problems delayed price rises.

Norcros (LON:NXR) (£278m | SR77)

Results for the 26 weeks ended 4 October 2026

Earnings per share rose 13.6% to 18.4p in the first half, helped by the Fibo acquisition, with a fall in margin the one blemish. Underlying operating profit rose 12.3% to £24.6m on revenue up 18.9%, but like-for-like sales grew only 1.5%. Leverage fell to 1.1x and the interim dividend rose 8.1% to 4.0p. Full-year profit is “in line with market expectations”.

BTG Consulting (LON:BTG) (£183m | SR80)

Half-year trading update

First-half profit and revenue are up, with full-year expectations on track. Revenue rose about 11%, including about 7% organic growth, while adjusted pre-tax profit rose about 15%. Net debt was £10.2m at 31 October 2026, against £5.7m a year earlier, after £6.4m of acquisition payments. It is confident of meeting analysts' forecasts of £26.5–26.9m adjusted pre-tax profit.

Liontrust Asset Management (LON:LIO) (£170m | SR92)

Liontrust Asset Mgmt - Half-year Financial Report

Adjusted pre-tax profit fell to £11.9m from £15.7m, and acquisition costs left a statutory pre-tax loss of £4.2m. Net outflows of £0.8bn were down from £2.3bn, and the 7.0p interim dividend is unchanged. Management is “cautious about the near-term flow environment”.

Ilika (LON:IKA) (£37m | SR8)

Trading Update & Notice of Half-Year Results

Solid-state battery maker Ilika is widening its Goliath sales push beyond cars into defence, marine and specialist mobility. Product revenue in the six months to 31 October 2026 was £90,000, up from £5,500, but total revenue fell to £0.4m from £0.6m. Cash was £6.3m. Further Stereax deliveries are expected in H1 2027.

*AI summaries are reviewed by the writing team.

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

1 comment


Avatar for Richard

Tracsis (LON:TRCS) results too

0
Get the free newsletter